These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31822888)

  • 1. Low High-Density Lipoprotein Cholesterol to Monitor Long-Term Average Increased Triglycerides.
    Langsted A; Jensen AMR; Varbo A; Nordestgaard BG
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31822888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
    Nordestgaard BG
    Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study.
    Quispe R; Manalac RJ; Faridi KF; Blaha MJ; Toth PP; Kulkarni KR; Nasir K; Virani SS; Banach M; Blumenthal RS; Martin SS; Jones SR
    Atherosclerosis; 2015 Sep; 242(1):243-50. PubMed ID: 26232164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
    Wittrup HH; Andersen RV; Tybjaerg-Hansen A; Jensen GB; Nordestgaard BG
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1438-45. PubMed ID: 16418216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.
    Quispe R; Martin SS; Jones SR
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.
    Jørgensen AB; Frikke-Schmidt R; West AS; Grande P; Nordestgaard BG; Tybjærg-Hansen A
    Eur Heart J; 2013 Jun; 34(24):1826-33. PubMed ID: 23248205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemfibrozil treatment of the high triglyceride-low high-density lipoprotein cholesterol trait in men with established atherosclerosis.
    Knipscheer HC; Nurmohamed MT; Van den Ende A; Plaat B; Pruijs HJ; Mulder WJ; Kastelein JJ
    J Intern Med; 1994 Oct; 236(4):377-84. PubMed ID: 7931040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial.
    Toth PP; Jones SR; Slee A; Fleg J; Marcovina SM; Lacy M; McBride R; Boden WE
    J Clin Lipidol; 2018; 12(3):741-747.e11. PubMed ID: 29627296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride as a risk factor for coronary artery disease.
    Gotto AM
    Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
    Waters DD; Bangalore S; Fayyad R; DeMicco DA; Laskey R; Melamed S; Barter PJ
    J Clin Lipidol; 2018; 12(2):356-366. PubMed ID: 29310989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remnant cholesterol as a causal risk factor for ischemic heart disease.
    Varbo A; Benn M; Tybjærg-Hansen A; Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG
    J Am Coll Cardiol; 2013 Jan; 61(4):427-436. PubMed ID: 23265341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in lipid profile in patients with acute myocardial infarction from two tertiary care hospitals in Pakistan.
    Iqbal MP; Shafiq M; Mehboobali N; Iqbal SP; Abbasi K
    J Pak Med Assoc; 2004 Nov; 54(11):544-9. PubMed ID: 15623178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between serum cholinesterase and incident hyper-LDL cholesterolemia, hypertriglyceridemia and hypo-HDL cholesterolemia as well as changes in lipid levels in a health screening population.
    Oda E
    Atherosclerosis; 2015 Jul; 241(1):1-5. PubMed ID: 25935113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High triglycerides to HDL-cholesterol ratio is associated with insulin resistance in normal-weight healthy adults.
    Pantoja-Torres B; Toro-Huamanchumo CJ; Urrunaga-Pastor D; Guarnizo-Poma M; Lazaro-Alcantara H; Paico-Palacios S; Del Carmen Ranilla-Seguin V; Benites-Zapata VA;
    Diabetes Metab Syndr; 2019; 13(1):382-388. PubMed ID: 30641729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL and triglyceride as therapeutic targets.
    Fruchart JC; Duriez P
    Curr Opin Lipidol; 2002 Dec; 13(6):605-16. PubMed ID: 12441884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.
    Quispe R; Al-Hijji M; Swiger KJ; Martin SS; Elshazly MB; Blaha MJ; Joshi PH; Blumenthal RS; Sniderman AD; Toth PP; Jones SR
    J Clin Lipidol; 2015; 9(4):511-8.e1-5. PubMed ID: 26228668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia.
    Karpov Y; Khomitskaya Y
    Cardiovasc Diabetol; 2015 Aug; 14():115. PubMed ID: 26303403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.